Your Money with Michelle Martin
About
Your Money With Michelle Martin (9am - 12pm) It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with “Influence” and hear from great authors in “Read”.
SEP 1, 2022
01/09/22 - Market View Minutes: Investments linked to the new Inflation Reduction ActHave you ever wanted to invest like Goldman Sachs? Well, today Michelle Martin looks at their latest research for about investments linked to the US’ new Inflation Reduction Act. The US is preparing to invest hundreds of billions of dollars in clean energy to help fight climate change. Which companies stand to benefit?
|
|
|
|
03:01
|
AUG 31, 2022
31/08/22 - Market View: China's largest developer record profit slump, Snap, Facebook, HP, PropNex, Marco Polo Marine, US Job vacanciesChina's largest developer recently reported a record 96% profit slump for the first half of this year. What kind of impact will this have on markets? In separate news, a Credit Suisse note recommends going underweight on stocks while Jefferies is predicting that the Fed will raise rates as high as 4 percent next year. What is the retail investor to read from these two different takes? Michelle Martin and Ryan Huang discuss what is moving markets today.
|
|
|
|
21:46
|
AUG 31, 2022
31/08/22 - Money and Me: How likely and to what extent could Singapore Banks suffer credit losses?What does the potential headwind of "higher-for-longer inflation" mean for Singapore banks across their entire portfolio? Michelle Martin finds out with Rena Kwok, Credit Analyst, Bloomberg intelligence
|
|
|
|
07:41
|
AUG 31, 2022
31/08/22 - Market View Minute: Bright spots in a gloomy marketThe mood in the markets is gloomy these days — and some investment banks, like Credit Suisse, say it may be better to keep more of your money on the sidelines, at least for the near term — but that doesn’t mean there aren’t bright spots and good opportunities. Where are brokers bullish? Michelle Martin looks at three across three very different industries - marine logistics, property and fintech.
|
|
|
|
03:11
|
AUG 30, 2022
30/08/22 - Market View: Pinduoduo to the moon, BYD strong profits, GoTo Hatten Land, Ambani + Adani, US Fed shrinks portfolioMichelle Martin and Ryan Huang help unpack the details behind Pinduoduo's latest earnings results, which saw its numbers beating estimates. They also explore the factors contributing to BYD's strong profits and find out which Asian became the World's Third-Richest Person.
|
|
|
|
20:25
|
AUG 30, 2022
30/08/22 - Market View Minutes: Property or fast food? Which are investors looking at?Jollibee’s is one of the most famous Filipino brands, and it has an aggressive expansion plan. But is it a good investment? We’ll see what the analysts are saying as we also examine a property company with a strong profit in this edition of Market View Minutes with Michelle Martin.
|
|
|
|
02:56
|
AUG 30, 2022
30/08/22 - Money and Me: How one Reddit Review spiked a huge increase in this company's salesWe meet the founder of All Citizens, a performance menswear company, 32-year old Danny Charbonnet. The brand counts 20,000 customers in America and Canada to date, plans to expand into the United Kingdom and Australia in the next year, and has bagged USD1.2 million pre-seed funding. How did this made in Singapore brand get its start?
|
|
|
|
20:27
|
AUG 29, 2022
29/08/22 - Market View: Fed Jerome Powell speech recap, September Slump, Sinopec, Amazon, Apple AR/VR Headset, Chinese economic growthWhat were some of the highlights of Fed Jerome Powell's recent speech and how are markets responding to it so far? As the Federal Reserve continues to slow the economy, which dividend stocks are worth watching out for? And would you consider being paid while watching 13 classic Stephen King horror movies? Michelle Martin and Ryan Huang bring in the details.
|
|
|
|
21:32
|
AUG 29, 2022
29/08/22 - Money and Me: How is Guardant Health improving clinical outcomes for cancer patients?Simranjit Singh is the CEO of Guardant Health, a precision oncology company that launched the first FDA-approved blood test for genomic testing across all solid cancers about 2 years ago. And just recently, Guardant Health AMEA was involved in a partnership with Adicon Holdings Limited, a leading independent clinical laboratory company based in China, to boost global research and diagnostic oncology efforts. Simranjit Singh joins Michelle Martin on Money and Me as he gives a breakdown of Guardant’s portfolio and efforts to effectively revolutionise the continuum of cancer care and improve clinical outcomes for cancer patients.
|
|
|
|
09:51
|
AUG 29, 2022
29/08/22 - Market View Minute: Thompson Medical Groups surge in profitsRunning vaccination clinics pays off for Thomson Medical which is reporting banner profits and dividends. How much? Michelle Martin finds out in Market View Minutes
|
|
|
|
02:38
|
